Abstract
BackgroundThe complexity of the tumor immune microenvironment (TIME) plays a critical role in immunotherapy treatment response, and this requires robust preclinical research models recapitulating patient-specific tumor-immune interactions.1 Immune oncology research...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
